Skip to main content
Caplight Logo









Isomorphic Labs

Isomorphic Labs

Private
LondonHealthcare & Life Scienceshttps://www.isomorphiclabs.com/

Last Round

Series B

May 12, 2026

Est. Valuation

$17.5B

Total Funding Raised

$2.94B

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Isomorphic Labs is a biotechnology company that uses an AI-first approach to reimagine the drug discovery process.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Medical AI, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Foundation

Keywords

drug discoverydigital biologyAlphaFoldprotein structure predictionAI drug discoverycomputational biologytherapeutic designfoundation modelsAI-driven therapeuticsin silico drug designmolecular modelingbiotech AIprecision medicinepharma R&D

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Isomorphic Labs Comparables

Compare Isomorphic Labs with similar companies based on industry and business-model similarity.

Isomorphic Labs comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Insilico Medicine
84%
Generate Biomedicines
83%
BenevolentAI
81%

Isomorphic Labs Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BMay 12, 2026
Series AMar 31, 2025
Corporate FundingSep 18, 2024
SpinoffNov 4, 2021

Isomorphic Labs Investors

Notable investors and investment history

Isomorphic Labs investors
InvestorRounds
UK Department for Science, Innovation and TechnologySeries B
TemasekSeries B
GVSeries B, Series A
Thrive CapitalSeries B, Series A
CapitalGSeries B
MGXSeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 17, 2026

    Monthly visitors increased 89% MoM.

  • May 12, 2026

    $2.0B raised, led by Thrive Capital.

Isomorphic Labs Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Isomorphic Labs Filings

SEC and related filings with document metadata.

Appears On

Curated lists and screens where this company is featured.

Frequently Asked Questions

Common questions about Isomorphic Labs's valuation, stock price, and market status.

Firmographic Details

HeadquartersLondon
Employee Range396
Year Founded2021
Last FundingMay 12, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?